BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 15528212)

  • 1. Myc antagonizes Ras-mediated growth arrest in leukemia cells through the inhibition of the Ras-ERK-p21Cip1 pathway.
    Vaqué JP; Navascues J; Shiio Y; Laiho M; Ajenjo N; Mauleon I; Matallanas D; Crespo P; León J
    J Biol Chem; 2005 Jan; 280(2):1112-22. PubMed ID: 15528212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ras induces p21Cip1/Waf1 cyclin kinase inhibitor transcriptionally through Sp1-binding sites.
    Kivinen L; Tsubari M; Haapajärvi T; Datto MB; Wang XF; Laiho M
    Oncogene; 1999 Nov; 18(46):6252-61. PubMed ID: 10597223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radicicol suppresses transformation and restores tropomyosin-2 expression in both ras- and MEK-transformed cells without inhibiting the Raf/MEK/ERK signaling cascade.
    Kim PN; Jonasch E; Mosterman BC; Mier JW; Janssen RA
    Cell Growth Differ; 2001 Nov; 12(11):543-50. PubMed ID: 11714635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myc represses the p21(WAF1/CIP1) promoter and interacts with Sp1/Sp3.
    Gartel AL; Ye X; Goufman E; Shianov P; Hay N; Najmabadi F; Tyner AL
    Proc Natl Acad Sci U S A; 2001 Apr; 98(8):4510-5. PubMed ID: 11274368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation and role of MAP kinase-dependent pathways in retinal pigment epithelial cells: ERK and RPE cell proliferation.
    Hecquet C; Lefevre G; Valtink M; Engelmann K; Mascarelli F
    Invest Ophthalmol Vis Sci; 2002 Sep; 43(9):3091-8. PubMed ID: 12202534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. H-, K- and N-Ras inhibit myeloid leukemia cell proliferation by a p21WAF1-dependent mechanism.
    Delgado MD; Vaqué JP; Arozarena I; López-Ilasaca MA; Martínez C; Crespo P; León J
    Oncogene; 2000 Feb; 19(6):783-90. PubMed ID: 10698496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polyamine-modulated c-Myc expression in normal intestinal epithelial cells regulates p21Cip1 transcription through a proximal promoter region.
    Liu L; Guo X; Rao JN; Zou T; Marasa BS; Chen J; Greenspon J; Casero RA; Wang JY
    Biochem J; 2006 Sep; 398(2):257-67. PubMed ID: 16706751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myc represses differentiation-induced p21CIP1 expression via Miz-1-dependent interaction with the p21 core promoter.
    Wu S; Cetinkaya C; Munoz-Alonso MJ; von der Lehr N; Bahram F; Beuger V; Eilers M; Leon J; Larsson LG
    Oncogene; 2003 Jan; 22(3):351-60. PubMed ID: 12545156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon-alpha2b reduces phosphorylation and activity of MEK and ERK through a Ras/Raf-independent mechanism.
    Romerio F; Riva A; Zella D
    Br J Cancer; 2000 Aug; 83(4):532-8. PubMed ID: 10945503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. UCN-01-induced cell cycle arrest requires the transcriptional induction of p21(waf1/cip1) by activation of mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase pathway.
    Facchinetti MM; De Siervi A; Toskos D; Senderowicz AM
    Cancer Res; 2004 May; 64(10):3629-37. PubMed ID: 15150122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Requirement for Ras/Raf/ERK pathway in naringin-induced G1-cell-cycle arrest via p21WAF1 expression.
    Kim DI; Lee SJ; Lee SB; Park K; Kim WJ; Moon SK
    Carcinogenesis; 2008 Sep; 29(9):1701-9. PubMed ID: 18296682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein kinase C isoforms involved in the transcriptional activation of cyclin D1 by transforming Ha-Ras.
    Kampfer S; Windegger M; Hochholdinger F; Schwaiger W; Pestell RG; Baier G; Grunicke HH; Uberall F
    J Biol Chem; 2001 Nov; 276(46):42834-42. PubMed ID: 11551901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein kinase C alpha trigger Ras and Raf-independent MEK/ERK activation for TPA-induced growth inhibition of human hepatoma cell HepG2.
    Wen-Sheng W
    Cancer Lett; 2006 Jul; 239(1):27-35. PubMed ID: 16169661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sp1 regulates Raf/MEK/ERK-induced p21(CIP1) transcription in TP53-mutated cancer cells.
    Karkhanis M; Park JI
    Cell Signal; 2015 Mar; 27(3):479-86. PubMed ID: 25595558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. As2O3-induced c-Src/EGFR/ERK signaling is via Sp1 binding sites to stimulate p21WAF1/CIP1 expression in human epidermoid carcinoma A431 cells.
    Liu ZM; Huang HS
    Cell Signal; 2006 Feb; 18(2):244-55. PubMed ID: 15961274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2-D gel electrophoresis-based proteomic analysis reveals that ormeloxifen induces G0-G1 growth arrest and ERK-mediated apoptosis in chronic myeloid leukemia cells K562.
    Pal P; Kanaujiya JK; Lochab S; Tripathi SB; Bhatt ML; Singh PK; Sanyal S; Trivedi AK
    Proteomics; 2011 Apr; 11(8):1517-29. PubMed ID: 21360677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional activation of p21(waf1/cip1) by alkylphospholipids: role of the mitogen-activated protein kinase pathway in the transactivation of the human p21(waf1/cip1) promoter by Sp1.
    De Siervi A; Marinissen M; Diggs J; Wang XF; Pages G; Senderowicz A
    Cancer Res; 2004 Jan; 64(2):743-50. PubMed ID: 14744793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opposite long-term regulation of c-Myc and p27Kip1 through overactivation of Raf-1 and the MEK/ERK module in proliferating human choroidal melanoma cells.
    Lefevre G; Calipel A; Mouriaux F; Hecquet C; Malecaze F; Mascarelli F
    Oncogene; 2003 Dec; 22(55):8813-22. PubMed ID: 14654778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. c-Myc inhibits Ras-mediated differentiation of pheochromocytoma cells by blocking c-Jun up-regulation.
    Vaqué JP; Fernández-García B; García-Sanz P; Ferrandiz N; Bretones G; Calvo F; Crespo P; Marín MC; León J
    Mol Cancer Res; 2008 Feb; 6(2):325-39. PubMed ID: 18314492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of c-Myc following MEK/ERK inhibition halts the expression of malignant phenotype in rhabdomyosarcoma and in non muscle-derived human tumors.
    Marampon F; Ciccarelli C; Zani BM
    Mol Cancer; 2006 Aug; 5():31. PubMed ID: 16899113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.